Syros Pharmaceuticals (SYRS)
(Delayed Data from NSDQ)
$1.92 USD
-0.01 (-0.52%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1.93 +0.01 (0.52%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Syros Pharmaceuticals, Inc. (SYRS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.75 | $20.00 | $4.00 | 353.37% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Syros Pharmaceuticals, Inc. comes to $8.75. The forecasts range from a low of $4.00 to a high of $20.00. The average price target represents an increase of 353.37% from the last closing price of $1.93.
Analyst Price Targets (4 )
Broker Rating
Syros Pharmaceuticals, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, five are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/13/2024 | JMP Securities | Jason N Butler | Strong Buy | Strong Buy |
8/13/2024 | Piper Sandler | Edward A Tenthoff | Strong Buy | Strong Buy |
8/12/2024 | Brookline Capital Markets | Leah R Cann | Strong Buy | Strong Buy |
7/31/2024 | Cowen & Co. | Philip M Nadeau | Strong Buy | Strong Buy |
6/26/2024 | H.C. Wainwright & Co. | Andrew S Fein | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 5 |
Average Target Price | $8.75 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -0.67 |
SYRS FAQs
Syros Pharmaceuticals, Inc. (SYRS) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Syros Pharmaceuticals, Inc. (SYRS) is $8.75. The current on short-term price targets is based on 3 reports.
The forecasts for Syros Pharmaceuticals, Inc. (SYRS) range from a low of $4 to a high of $20. The average price target represents a increase of $353.37 from the last closing price of $1.93.
The current UPSIDE for Syros Pharmaceuticals, Inc. (SYRS) is 353.37%
Based on short-term price targets offered by four analysts, the average price target for Syros Pharmaceuticals, Inc. comes to $8.75. The forecasts range from a low of $4.00 to a high of $20.00. The average price target represents an increase of 353.37% from the last closing price of $1.93.